Okta, Inc. balance sheet OKTA

As of Jul 31, 2026, Okta, Inc. had total assets of $9.1 billion and total liabilities of $2.2 billion. Total assets were down 4.3% from a year earlier. Stockholders' equity was $7.0 billion. It held $2.3 billion in cash and investments against $53.0 million of total debt, net cash of $2.2 billion. The current ratio, current assets divided by current liabilities, was 1.53.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2027
Jul 31, 2026
FY 2026
Jan 31, 2026
FY 2025
Jan 31, 2025
FY 2024
Jan 31, 2024
FY 2023
Jan 31, 2023
FY 2022
Jan 31, 2022
FY 2021
Jan 31, 2021
FY 2020
Jan 31, 2020
FY 2019
Jan 31, 2019
FY 2018
Jan 31, 2018
Assets
Cash
763
-12.9%
858
+109.8%
409
+22.5%
334
+26.5%
264
+1.5%
260
-40.2%
435
-16.4%
520
+74.3%
298
+133.2%
128
Short-term investments
1,536
-22.5%
—
2,114
+13.2%
1,868
-19.3%
2,316
+3.3%
2,242
+5.7%
2,122
+140.3%
883
+232.7%
265
+160.8%
102
Cash and investments
2,299
-19.6%
858
-66.0%
2,523
+14.6%
2,202
-14.7%
2,580
+3.1%
2,502
-2.1%
2,557
+82.2%
1,403
+148.9%
564
+145.4%
230
Receivables
469
+12.5%
687
+10.6%
621
+11.1%
559
+16.2%
481
+20.9%
398
+104.3%
195
+49.7%
130
+41.5%
92
+75.9%
52
Total current assets
3,089
-13.4%
3,644
+6.7%
3,416
+14.6%
2,980
-7.7%
3,229
+6.2%
3,041
+5.6%
2,879
+79.9%
1,600
+125.9%
708
+123.0%
317
Property and equipment, net
33
-15.4%
38
-11.6%
43
-10.4%
48
-18.6%
59
-9.2%
65
+3.5%
63
+17.3%
54
+1.2%
53
+322.0%
13
Goodwill
5,487
+0.7%
5,487
+0.7%
5,448
+0.8%
5,406
+0.1%
5,400
-0.0%
5,401
+11146.7%
48
+0.0%
48
+165.5%
18
+187.9%
6
Total assets
9,138
-4.3%
9,710
+2.9%
9,437
+5.0%
8,989
-3.4%
9,307
+1.1%
9,206
+179.1%
3,299
+68.7%
1,955
+98.7%
984
+146.5%
399
Liabilities and equity
Accounts payable
10
-16.7%
12
-7.7%
13
+8.3%
12
+0.0%
12
-40.0%
20
+133.7%
9
+123.0%
4
+57.8%
2
-74.6%
10
Total current liabilities
2,025
-23.5%
2,554
+1.2%
2,523
+41.6%
1,782
+21.6%
1,465
+17.9%
1,243
-19.6%
1,546
+182.6%
547
-4.6%
573
+204.9%
188
Total liabilities
2,165
-22.6%
2,711
-10.6%
3,032
-2.2%
3,101
-19.3%
3,841
+17.0%
3,284
+26.1%
2,605
+68.0%
1,550
+111.8%
732
+266.1%
200
Stockholders' equity
6,973
+3.2%
6,999
+9.3%
6,405
+8.8%
5,888
+7.7%
5,466
-7.7%
5,922
+754.5%
693
+71.1%
405
+60.5%
252
+26.6%
199
Debt
Lease liabilities
53
-34.6%
101
-16.5%
121
-14.8%
142
-18.9%
175
-11.2%
197
-3.0%
203
+21.9%
167
—
—
Total debt
53
-34.6%
101
-16.5%
121
-14.8%
142
-18.9%
175
-11.2%
197
-3.0%
203
+21.9%
167
—
—
Net cash
2,246
-19.1%
757
-68.5%
2,402
+16.6%
2,060
-14.3%
2,405
+4.3%
2,305
-2.1%
2,353
+90.3%
1,236
—
—
Ratios
Current ratio
1.53x
1.43x
1.35x
1.67x
2.20x
2.45x
1.86x
2.92x
1.24x
1.69x
Debt to equity
0.01x
0.01x
0.02x
0.02x
0.03x
0.03x
0.29x
0.41x
—
—
Debt to EBITDA
—
0.62x
—
—
—
—
—
—
—
—
Return on equity
4.24%
3.36%
0.44%
-6.03%
-14.91%
-14.32%
-38.38%
-51.58%
-49.73%
-55.11%
Return on assets
3.24%
2.42%
0.30%
-3.95%
-8.76%
-9.21%
-8.06%
-10.68%
-12.75%
-27.51%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
OKTA (Nasdaq)
Fiscal year ends
January 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1660134

Other Services-Prepackaged Software companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.